• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

作者信息

Hochhaus A, Saussele S, Rosti G, Mahon F-X, Janssen J J W M, Hjorth-Hansen H, Richter J, Buske C

出版信息

Ann Oncol. 2018 Oct 1;29(Suppl 4):iv261. doi: 10.1093/annonc/mdy159.

DOI:10.1093/annonc/mdy159
PMID:30285223
Abstract
摘要

相似文献

1
Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.慢性髓性白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv261. doi: 10.1093/annonc/mdy159.
2
Corrigendum to 'Acute myeloid leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Annals of Oncology Volume 31, Issue 6, June 2020, Pages 697-712].《成人急性髓系白血病：ESMO诊断、治疗及随访临床实践指南》勘误：[《肿瘤学年鉴》第31卷，第6期，2020年6月，第697 - 712页]
Ann Oncol. 2021 Jun;32(6):821. doi: 10.1016/j.annonc.2021.04.005. Epub 2021 Apr 20.
3
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.成年患者急性淋巴细胞白血病：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v69-v82. doi: 10.1093/annonc/mdw025. Epub 2016 Apr 7.
4
Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.欧洲肿瘤内科学会（ESMO）与美国国立综合癌症网络（NCCN）乳腺癌指南之间的差异：一项评估。
Breast. 2015 Aug;24(4):513-23. doi: 10.1016/j.breast.2015.02.031. Epub 2015 Mar 25.
5
Long-term follow-up for up to 5 years on the risk of leukaemic progression in thrombocytopenic patients with lower-risk myelodysplastic syndromes treated with romiplostim or placebo in a randomised double-blind trial.在一项随机双盲试验中，对接受罗米司亭或安慰剂治疗的低风险骨髓增生异常综合征血小板减少患者白血病进展风险进行长达5年的长期随访。
Lancet Haematol. 2018 Mar;5(3):e117-e126. doi: 10.1016/S2352-3026(18)30016-4. Epub 2018 Jan 26.
6
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.酪氨酸激酶抑制剂治疗慢性髓性白血病的停药研究（EURO-SKI）：一项前瞻性、多中心、非随机、试验的预先指定的中期分析。
Lancet Oncol. 2018 Jun;19(6):747-757. doi: 10.1016/S1470-2045(18)30192-X. Epub 2018 May 4.
7
A case-control study to investigate the risk of leukaemia associated with exposure to benzene in petroleum marketing and distribution workers in the United Kingdom.一项病例对照研究，旨在调查英国石油营销与配送工人接触苯与患白血病风险之间的关联。
Occup Environ Med. 1997 Mar;54(3):152-66. doi: 10.1136/oem.54.3.152.
8
Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.胆管癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v28-v37. doi: 10.1093/annonc/mdw324.
9
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.食管癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v50-v57. doi: 10.1093/annonc/mdw329.
10
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.直肠癌：欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv263. doi: 10.1093/annonc/mdy161.

引用本文的文献

1
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions.慢性髓性白血病的无治疗缓解：重新审视“W”问题。
Eur J Haematol. 2025 Sep;115(3):218-231. doi: 10.1111/ejh.70000. Epub 2025 Jun 23.
2
Asciminib in the treatment of chronic myeloid leukemia in chronic phase.阿伐替尼治疗慢性期慢性髓性白血病
Future Oncol. 2025 Mar;21(7):815-831. doi: 10.1080/14796694.2025.2464494. Epub 2025 Feb 12.
3
Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia.
对波舒替尼用于治疗慢性髓性白血病的临床数据及基于专家意见的建议的批判性综述。
Front Oncol. 2024 Aug 26;14:1405467. doi: 10.3389/fonc.2024.1405467. eCollection 2024.
4
A Case of Hepatocellular Carcinoma after Treatment for Chronic Myeloid Leukemia in a Patient without Liver Disease.一名无肝脏疾病患者在接受慢性髓性白血病治疗后发生肝细胞癌的病例。
Case Rep Oncol. 2024 Jul 25;17(1):788-796. doi: 10.1159/000540260. eCollection 2024 Jan-Dec.
5
A Retrospective Analysis of Kinase Domain Mutations in the Frontline Drug Intolerant or Resistant Chronic Myeloid Leukemia Patients: An Indian Experience from a High-End Referral Laboratory.一线药物不耐受或耐药慢性髓性白血病患者激酶结构域突变的回顾性分析：来自一家高端转诊实验室的印度经验。
South Asian J Cancer. 2022 Dec 31;13(2):132-141. doi: 10.1055/s-0042-1757911. eCollection 2024 Apr.
6
Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: Clinical Relevance, Impact on Outcome, Preventive Measures and Treatment Strategies.酪氨酸激酶抑制剂在慢性髓性白血病中的心血管不良事件：临床相关性、对预后的影响、预防措施及治疗策略
Curr Treat Options Oncol. 2023 Dec;24(12):1720-1738. doi: 10.1007/s11864-023-01149-1. Epub 2023 Dec 4.
7
Association of polymorphisms with imatinib treatment outcome in Azerbaijani chronic myeloid leukaemia patients.阿塞拜疆慢性髓性白血病患者中基因多态性与伊马替尼治疗效果的关联。
Indian J Med Res. 2023 Aug;158(2):151-160. doi: 10.4103/ijmr.ijmr_1103_22.
8
A multicenter real-world evidence study in the Swiss treatment landscape of chronic myeloid leukemia.瑞士慢性髓性白血病治疗现状的多中心真实世界研究。
BMC Cancer. 2022 Nov 19;22(1):1192. doi: 10.1186/s12885-022-10241-y.
9
Adverse events and dose modifications of tyrosine kinase inhibitors in chronic myelogenous leukemia.慢性粒细胞白血病中酪氨酸激酶抑制剂的不良事件及剂量调整
Front Oncol. 2022 Oct 6;12:1021662. doi: 10.3389/fonc.2022.1021662. eCollection 2022.
10
Application of precision medicine in clinical routine in haematology-Challenges and opportunities.精准医学在血液学临床常规中的应用——挑战与机遇。
J Intern Med. 2022 Aug;292(2):243-261. doi: 10.1111/joim.13508. Epub 2022 Jun 4.